10 research outputs found

    Role of dual antiplatelet therapy in symptomatic patients with established vascular disease:putting the CHARISMA trial into therapeutic perspective

    No full text
    The CHARISMA (Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance) trial has spurred debate over subgroup analysis interpretation and prompted renewed consideration of the long-term role of dual aspirin and clopidogrel therapy (DAPT) in patients with established vascular disease

    Amputation Surgeries for the Lower Limb

    No full text
    corecore